SlideShare a Scribd company logo
Merck KGaA
Darmstadt, Germany
Authors: Marine Maszelin, Emilie Egloff, Nargisse El Hajjami,
Josselyn Haas Durr, Nina Weis
Process Scale
chromatography
M Lab™ Collaboration Center Demonstration Day
01
02
03
Agenda
2
Introduction
Chromatography Theory
Next Generation Chromatography
For Upstream,
Downstream, and
Final Fill, our non-
GMP facilities are
resource hubs for:
• Application &
Technology
Demonstrations
• Education
• Complex Process
Development,
Optimization, and
Scale-Up
• Troubleshooting and
Unit Operation
Support
• Analytical Modelling
• Customer Sizing and
Simulation Tools &
Methodologies
M Lab™ Collaboration Centers
Singapore
Molsheim,
France
Sao Paulo,
Brazil
Burlington,
USA
Mumbai,
India
Bangalore,
India
Shanghai,
China
Tokyo,
Japan
Incheon,
South Korea
1904
1930
1950s
1970s
/80s
1989
1991
1992
1995
2004
2005
2008
2009
2011
2012
2010
2016
2013 2017
Aluminium
Oxide
Silica Gel
ProSep® vA HC
Fractogel® EMD SO3
(M), TMAE (M), DMAE
(M), DEAE (M)
Fractogel®
EMD Chelate
Fractogel® EMD
SE Hicap (M),
COO (M)
ProSep®
vA Ultra
Eshmuno® S
Eshmuno® Q
Eshmuno® HCX
Eshmuno® CPX
PharmPrep® P
Eshmuno® A
Eshmuno® P
anti-A &
P anti-B
Natrix® Q
Fractogel® EMD
TMAE Medcap
Fractogel® EMD
BioSEC, TMAE
Hicap (M), SO3
(S), TMAE (S)
Calcium
Carbonate LiChroprep®
ProSep®
Ultra Plus
2020
Eshmuno® CMX
A Long History of Bringing Innovative Products to Market
2018
Eshmuno® CP-FT
Eshmuno® CPS
01
02
03
Agenda
5
Introduction
Chromatography Theory
Next Generation Chromatography
Used to separate chemical
or biological components of
a mixture for later use,
and a powerful step in the
drug purification process.
Used for the quantitation and
identification of chemical or
biological compounds to
establish relative proportions of
analytes in a mixture.
Analytical
Chromatography
Preparative
Chromatography
VS
The Goal of Preparative Chromatography
Isolation of the target compound from a crude
feedstock as economical as possible!
... as fast as possible
... as pure as possible
... as much as possible
... as highly concentrated as possible
Chromatographic Steps
Equilibrate
Column is
conditioned to
suitable pH, ionic
strength, polarity,
and hydrophobicity
for mobile phase A
Load
Sample containing
solutes is applied to
the chromatographic
bed
Wash
Bound solutes are
washed with mobile
phase A to remove
unwanted and
unbounded
molecules
Elute
Target molecule is
eluted from the
chromatographic
bed by changing
conditions to
mobile phase B
Regenerate
Re-equilibration of
the chromatographic
medium to the initial
mobile phase
conditions
Chromatography
Resin
Target Protein
Unwanted molecules
9
• Enables enhanced mAb purity which are positively charged
• Removal of DNA, endotoxins, host cell protein and leached
protein A ligands
• May be efficient in reducing aggregates
• Efficient method for capturing monoclonal antibodies (mAbs)
• Removal of trace contaminants such as nucleic
acids and host cell proteins to reach the highest
level of mAb purity
• Contribute to the overall viral clearance strategy
for mammalian cell processes
How Chromatography is used in a Drug: mAb Purification Process
Types of Chromatography and How They Are Used
Mode Affinity Ion
Exchange
Reverse
Phase
Membrane Hydrophobic
Interaction
Size
Exclusion
Capture
Purification
Polishing
Capture: step used to isolate and
concentrate the target molecule
Moderate to High Purity | High Yield
Purification: step used to remove
bulk impurities
Very High Purity | Balanced Yield
Polishing: step used to remove final
contaminants
Highest Purity | Moderate Yield
Which Impurities are Removed by Chromatography Type
Host Cell
Proteins
DNA Virus Leached
Protein A
Aggregates
Protein A
Cation
Exchange
Anion
Exchange
Somewhat
Effective
Moderately
Effective
Extremely
Effective
Marginally
Effective
Very
Effective
Products to Suit a Diversified Landscape of Molecules
Type of molecule Chromatography Mode
Monoclonal antibody
• Affinity
• Ion exchange
• Mixed-mode
Other recombinant proteins
• Ion exchange
• Mixed-mode
• Reversed phase
• Affinity
• Size exclusion
Plasma protein
• Ion exchange
• Size exclusion
• Affinity
Vaccine
• Ion exchange
• Size exclusion
Small molecule, peptide
• Reversed phase
• Ion exchange
Removal of impurties
For example:
• Aggregates
• Fragments
• Charge variants
• HCPs (Host Cell
Proteins)
• DNA
• Virus
• Endotoxin
• Proteases
Impurities depend on
expression system,
product, and process.
Theoretical Plates Theory
Assumption:
Column consists of a
large number of
imaginary layers
Separation Action:
analytes equilibrate
between the mobile
and stationary phase
in each layer
Column Efficiency:
measured by
calculating the
height equivalent of
a theoretical plate
(HETP)
Theoretical Plate
Column
Retention Time
DetectorResponse
How to read a Chromatogram
Injection
Retention Time = time between injection and detection of analyte
(Capacity factor)
Obtaining the
optimum resolution
(Rs) in the minimum
time is the goal when
optimizing
chromatographic
steps
Rs= Retention x
Selectivity x Efficiency
Efficiency
Selectivity (Separation Factor)
Peak maximum
ability of the chromatographic system
to ‘chemically’ distinguish between
sample components
Elution of unbound
molecules
Elution of unwanted
material
Elution of target
molecule
Elution of tightly
bound molecules
Retention Time
DetectorResponse
10-20 Column Volumes
2-4 Column Volumes
2-4 Column Volumes
4 Column VolumesHow to read a Chromatogram
Base Bead
A
A
A
A
A
A
A
AAA
A
A
A
A
A
A
A
A
A
A A A
A
Variable Region
Fc Fragment
Fab Fragment
F(ab)₂ Fragment
Heavy Chains Light Chains
Specific and selective interaction
between target molecule and resin
Protein A Affinity Chromatography: Separation Principle
Ion Chromatography: Separation Principle
Base Bead
Negatively Charged
Bound Protein
Positively Charged Ligand
Unbound Protein
Bind: proteins attach as they are
loaded onto the column at low
ionic strength
Elute: performed by increasing salt
concentration or changing pH to
retrieve attached target protein
Architecture of Chromatographic Resins
O
O
H3N+-
Si
O H
H O
H
CH3 CH3
R R R R
R R R OH
OH
Base Material
porous, spherical or
irregular shaped
particles in the µm-
range
Linker
linear or branched
chains or tentacles to
present the ligands in
an optimal way.
Ligand
Point of Interaction
on molecular level:
(ionic, hydrophobic,
H-bridges, π-π-
interaction)
Three main parts: Base Material, Linker and Ligand
Hydraulic Properties
Spherical or Irregular
Average size and
distribution
Functionality
Pore diameter and
volume
1 Shape
2 Size
3 Porosity
4 Rigidity
5 Chemistry
Chromatography Resin – Heart of the Chromatography Unit Operation
+ More Efficient
+ Good mass transfer
- Higher pressure drop
- More expensive
- Less Efficient
- Poorer Mass Transfer
+ Lower pressure drop
+ Less Expensive
vs.
+ Larger surface area
→ larger capacity
+ Stronger
- Poorer mass transfer
- Less surface area
→ less capacity
- weaker
+ Better mass transfer
vs.
Different Column Dimensions
© Copyright Merck KGaA, Darmstadt Germany
Lab-scale, analytical HPLC-instruments
Semi-prep
4 mm
10 mm
25 mm
50 mm
100 mm
400 mm
Process-scale
800 mm
Chromatography Resin Properties and the Factors They Influence
Resolution, product
purity, removal of
impurities, pressure
drop, dynamic
capacity
Throughput,
potential scale of
manufacturing,
maximum operating
velocity
1
Binding capacity,
selectivity, and
recovery
2
Lifespan, ease and
efficacy of
sanitization, and
effectiveness of
cleaning in place
5
4
Dynamic binding
capacity, flow rate
3
Product recovery,
and effectiveness of
cleaning in place
6
Mechanical
Properties
Ligand Density
& Distribution
Pore Size &
Distribution
Particle Size &
Distribution
Chemical
Stability
Hydrophilicity &
Hydrophobicity
Source: Handbook of Process Chromatography – Development, Manufacturing, Validation and Economics. 2nd Edition. 2008,
Hagel, Gunter, Sofer. <https://www.sciencedirect.com/book/9780123740236/handbook-of-process-chromatography>
• Increase Diameter
• Constant Bed Height &
Linear Flow Rate
Scale-Up
22
Preserve the quality of separation achieved at small scale
in order to produce comparable results at large scale
Economic Scale-Up
Challenges
1) Column Size
2) Reuse & Cycles
3) Throughput
4) Costs
Technical Scale-Up
Challenges
1) Quality of the
Separation
2) Comparable Results
Impacts
1) Capacity
2) Column Loading
3) Product Titer
4) Lot Size
Impacts
1) Process Parameters
2) Packing Efficiency
3) Pressure Drop
Constraints
4) Flow Distribution
Conventional Scale-Up1
Residence Time Scale-Up2
• Linear increase of Bed
Height & Flow Rate
• Pressure-Flow Limitations
Due to Compressibility
Combined Scale-Up2
• Modern resin maintain
low pressure drop
• Permits scale-up in any
dimension at constant
residence time
• Greater equipment
flexibility
01
02
03
Agenda
23
Introduction
Chromatography Theory
Next Generation Chromatography
2018
2018-2020+
>2025
Biomanufacturing moves to the next generation of biotherapeutic
production with the BioContinuum™ Platform
Smaller
Footprint
Less
Capital Intense
Reduction in
Construction Time
Reduction in
OPEX
90%
90%
70%
90%
Intensified Upstream
& harvest
Intensified
Capture
In-Line VI
In-Line Buffer
Flow Through
Polishing
Continuous
UFDF
The next generation of chromatography will be important for
intensified biomanufacturing and continuous processing
✓ Reduced Footprint
✓ Enhanced Utilization of Protein A Resin
✓ Enables Single-Use and Closed Operations
✓ Increased Productivity
✓ Reduced Footprint & Capital Expenditure
✓ Reduces Consumables Needed Including
Buffer Requirements
✓ Enables Single-Use and Closed Operations
✓ Reduced Set-Up and Switching Time
26
Bioreactor Virus Filtration UF/DFProtein A f/t CEX f/t AEXFiltration
Eshmuno® CP-FT resin: a novel cation exchange resin used for flow
through polishing
Tentacular Ligand
Chemistry AggregatesMonomer
Eshmuno® CP-FT resin: Reduces the volume of columns required to
purify 1 kg of mAb
Volume for 80 g/L
Loading
Volume for 1000 g/L
Loading
Traditional CEX Media
Bind/Elute Chromatography
Eshmuno® CP-FT resin
Flow-Through Chromatography
20cmbedheight
20cmbedheight
12.5 L 1 Lvs.
Stay connected!
Email: chromconnect@merckgroup.com
to sign up for our Quarterly Newsletter
Follow Your
Curiosity
Schedule an in-person or remote
visit today.
MerckMillipore.com/mlab
The vibrant M, M Lab, LiChroprep, Fractogel, Eshmuno, Natrix, ProSep, PharmPrep, and BioContinuum are trademarks of Merck KGaA, Darmstadt, Germany or
its affiliates. All other trademarks are the property of their respective owners. Detailed information on trademarks is available via publicly accessible
resources.
© 2020 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.

More Related Content

What's hot

Validation of Tangential Flow Filtration in Biotech Processes
Validation of Tangential Flow Filtration in Biotech ProcessesValidation of Tangential Flow Filtration in Biotech Processes
Validation of Tangential Flow Filtration in Biotech Processes
Merck Life Sciences
 
Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)
Merck Life Sciences
 
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
Merck Life Sciences
 
Normal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale UpNormal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale Up
MilliporeSigma
 
Cross Flow or Tangential Flow Membrane Filtration (TFF) to Enable High Solids...
Cross Flow or Tangential Flow Membrane Filtration (TFF) to Enable High Solids...Cross Flow or Tangential Flow Membrane Filtration (TFF) to Enable High Solids...
Cross Flow or Tangential Flow Membrane Filtration (TFF) to Enable High Solids...
njcnews777
 
Improvement in Protein A Resin Lifetime
Improvement in Protein A Resin LifetimeImprovement in Protein A Resin Lifetime
Improvement in Protein A Resin Lifetime
Merck Life Sciences
 
Cell distruption
Cell distruptionCell distruption
Cell distruption
eswar1810
 
Normal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale UpNormal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale Up
Merck Life Sciences
 
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
MilliporeSigma
 
Scale-up of high area filters for microfiltration of biological fluids - Poin...
Scale-up of high area filters for microfiltration of biological fluids - Poin...Scale-up of high area filters for microfiltration of biological fluids - Poin...
Scale-up of high area filters for microfiltration of biological fluids - Poin...
MilliporeSigma
 
Single-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Single-Pass Tangential Flow Filtration (SPTFF) Theory and PracticeSingle-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Single-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Merck Life Sciences
 
Lyophilization 1
Lyophilization   1Lyophilization   1
Lyophilization 1
Asmaira RZ
 
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On ExperienceParvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Merck Life Sciences
 
High pressure homogenization
High pressure homogenizationHigh pressure homogenization
High pressure homogenization
Anil Pethe
 
Membrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Membrane Chromatography Solutions for Single-Use, Intensified mAb PurificationMembrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Membrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Merck Life Sciences
 
Introduction to RP-HPLC
Introduction to RP-HPLCIntroduction to RP-HPLC
Introduction to RP-HPLC
Karthi Kumar
 
Process Development for Continuous Flow-Through Polishing Purification for mA...
Process Development for Continuous Flow-Through Polishing Purification for mA...Process Development for Continuous Flow-Through Polishing Purification for mA...
Process Development for Continuous Flow-Through Polishing Purification for mA...
Merck Life Sciences
 
Find your filter. What’s best for your process?
Find your filter. What’s best for your process? Find your filter. What’s best for your process?
Find your filter. What’s best for your process?
MilliporeSigma
 
Expanded bed chromatography
Expanded bed chromatographyExpanded bed chromatography
Expanded bed chromatography
Sakshi Saxena
 
Single-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Single-Pass Tangential Flow Filtration (SPTFF) Theory and PracticeSingle-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Single-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
MilliporeSigma
 

What's hot (20)

Validation of Tangential Flow Filtration in Biotech Processes
Validation of Tangential Flow Filtration in Biotech ProcessesValidation of Tangential Flow Filtration in Biotech Processes
Validation of Tangential Flow Filtration in Biotech Processes
 
Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)Introduction to Tangential Flow Filtration (TFF)
Introduction to Tangential Flow Filtration (TFF)
 
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
High Productivity Membrane Chromatography: Enabling the Next Generation Biopr...
 
Normal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale UpNormal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale Up
 
Cross Flow or Tangential Flow Membrane Filtration (TFF) to Enable High Solids...
Cross Flow or Tangential Flow Membrane Filtration (TFF) to Enable High Solids...Cross Flow or Tangential Flow Membrane Filtration (TFF) to Enable High Solids...
Cross Flow or Tangential Flow Membrane Filtration (TFF) to Enable High Solids...
 
Improvement in Protein A Resin Lifetime
Improvement in Protein A Resin LifetimeImprovement in Protein A Resin Lifetime
Improvement in Protein A Resin Lifetime
 
Cell distruption
Cell distruptionCell distruption
Cell distruption
 
Normal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale UpNormal Flow Filtration: Design and Scale Up
Normal Flow Filtration: Design and Scale Up
 
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
An Integrated Approach to Ensure Viral Vector and Gene Therapy Commercial Rea...
 
Scale-up of high area filters for microfiltration of biological fluids - Poin...
Scale-up of high area filters for microfiltration of biological fluids - Poin...Scale-up of high area filters for microfiltration of biological fluids - Poin...
Scale-up of high area filters for microfiltration of biological fluids - Poin...
 
Single-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Single-Pass Tangential Flow Filtration (SPTFF) Theory and PracticeSingle-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Single-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
 
Lyophilization 1
Lyophilization   1Lyophilization   1
Lyophilization 1
 
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On ExperienceParvovirus Filtration Best Practices - 25 Years of Hands-On Experience
Parvovirus Filtration Best Practices - 25 Years of Hands-On Experience
 
High pressure homogenization
High pressure homogenizationHigh pressure homogenization
High pressure homogenization
 
Membrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Membrane Chromatography Solutions for Single-Use, Intensified mAb PurificationMembrane Chromatography Solutions for Single-Use, Intensified mAb Purification
Membrane Chromatography Solutions for Single-Use, Intensified mAb Purification
 
Introduction to RP-HPLC
Introduction to RP-HPLCIntroduction to RP-HPLC
Introduction to RP-HPLC
 
Process Development for Continuous Flow-Through Polishing Purification for mA...
Process Development for Continuous Flow-Through Polishing Purification for mA...Process Development for Continuous Flow-Through Polishing Purification for mA...
Process Development for Continuous Flow-Through Polishing Purification for mA...
 
Find your filter. What’s best for your process?
Find your filter. What’s best for your process? Find your filter. What’s best for your process?
Find your filter. What’s best for your process?
 
Expanded bed chromatography
Expanded bed chromatographyExpanded bed chromatography
Expanded bed chromatography
 
Single-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Single-Pass Tangential Flow Filtration (SPTFF) Theory and PracticeSingle-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
Single-Pass Tangential Flow Filtration (SPTFF) Theory and Practice
 

Similar to Process Scale Chromatography

Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...
KBI Biopharma
 
sawsan-mohamed-amer-cairo-university-egypt.pptx
sawsan-mohamed-amer-cairo-university-egypt.pptxsawsan-mohamed-amer-cairo-university-egypt.pptx
sawsan-mohamed-amer-cairo-university-egypt.pptx
EhabAdel29
 
11639_10ububhbunubtbinuhubjbubijub061.pdf
11639_10ububhbunubtbinuhubjbubijub061.pdf11639_10ububhbunubtbinuhubjbubijub061.pdf
11639_10ububhbunubtbinuhubjbubijub061.pdf
vaibhavbarde287
 
Innovation in size based polymer separations
Innovation in size based polymer separationsInnovation in size based polymer separations
Innovation in size based polymer separations
Waters Corporation - Chemical Materials
 
Industrial Applications Of Chromatography Technique
Industrial Applications Of Chromatography TechniqueIndustrial Applications Of Chromatography Technique
Industrial Applications Of Chromatography Technique
rita martin
 
Platforms for mAb Commercialization
Platforms for mAb Commercialization Platforms for mAb Commercialization
Platforms for mAb Commercialization
KBI Biopharma
 
CHROMacademy Premier Membership Brochure
CHROMacademy Premier Membership BrochureCHROMacademy Premier Membership Brochure
CHROMacademy Premier Membership Brochure
abasis
 
Tongkat Ali Extraction Process
Tongkat Ali Extraction ProcessTongkat Ali Extraction Process
Tongkat Ali Extraction Process
Saiful Irwan Zubairi
 
Particles in the Biotech Product Life Cycle: Analysis, Identification and Con...
Particles in the Biotech Product Life Cycle: Analysis, Identification and Con...Particles in the Biotech Product Life Cycle: Analysis, Identification and Con...
Particles in the Biotech Product Life Cycle: Analysis, Identification and Con...
SGS
 
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
MilliporeSigma
 
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Merck Life Sciences
 
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD ParadigmCustom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
MilliporeSigma
 
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD ParadigmCustom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Merck Life Sciences
 
Method developmment, trouble shooting ppt
Method developmment, trouble shooting pptMethod developmment, trouble shooting ppt
Method developmment, trouble shooting ppt
rdeepthi1
 
Cornell Computational Chemistry Seminar
Cornell Computational Chemistry SeminarCornell Computational Chemistry Seminar
Cornell Computational Chemistry Seminar
George Fitzgerald
 
Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial TestingBiopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing
KBI Biopharma
 
Design Space
Design SpaceDesign Space
From Screening to QC: Development Considerations for Octet Methods
From Screening to QC: Development Considerations for Octet MethodsFrom Screening to QC: Development Considerations for Octet Methods
From Screening to QC: Development Considerations for Octet Methods
KBI Biopharma
 
Monoclonal antibodies,Production + bioseperartion
Monoclonal antibodies,Production + bioseperartionMonoclonal antibodies,Production + bioseperartion
Monoclonal antibodies,Production + bioseperartion
shadan87
 
Process Development for Continuous Flow-Through Polishing Purification for mA...
Process Development for Continuous Flow-Through Polishing Purification for mA...Process Development for Continuous Flow-Through Polishing Purification for mA...
Process Development for Continuous Flow-Through Polishing Purification for mA...
MilliporeSigma
 

Similar to Process Scale Chromatography (20)

Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...Fine-tuning your purification process: Using mechanistic modeling of chromato...
Fine-tuning your purification process: Using mechanistic modeling of chromato...
 
sawsan-mohamed-amer-cairo-university-egypt.pptx
sawsan-mohamed-amer-cairo-university-egypt.pptxsawsan-mohamed-amer-cairo-university-egypt.pptx
sawsan-mohamed-amer-cairo-university-egypt.pptx
 
11639_10ububhbunubtbinuhubjbubijub061.pdf
11639_10ububhbunubtbinuhubjbubijub061.pdf11639_10ububhbunubtbinuhubjbubijub061.pdf
11639_10ububhbunubtbinuhubjbubijub061.pdf
 
Innovation in size based polymer separations
Innovation in size based polymer separationsInnovation in size based polymer separations
Innovation in size based polymer separations
 
Industrial Applications Of Chromatography Technique
Industrial Applications Of Chromatography TechniqueIndustrial Applications Of Chromatography Technique
Industrial Applications Of Chromatography Technique
 
Platforms for mAb Commercialization
Platforms for mAb Commercialization Platforms for mAb Commercialization
Platforms for mAb Commercialization
 
CHROMacademy Premier Membership Brochure
CHROMacademy Premier Membership BrochureCHROMacademy Premier Membership Brochure
CHROMacademy Premier Membership Brochure
 
Tongkat Ali Extraction Process
Tongkat Ali Extraction ProcessTongkat Ali Extraction Process
Tongkat Ali Extraction Process
 
Particles in the Biotech Product Life Cycle: Analysis, Identification and Con...
Particles in the Biotech Product Life Cycle: Analysis, Identification and Con...Particles in the Biotech Product Life Cycle: Analysis, Identification and Con...
Particles in the Biotech Product Life Cycle: Analysis, Identification and Con...
 
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
 
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
Implementing a Fully Single-Use, Integrated mAb Biosimilars Purification Plat...
 
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD ParadigmCustom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
 
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD ParadigmCustom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
Custom Affinity Chromatography for Vaccine Purification: A New PD Paradigm
 
Method developmment, trouble shooting ppt
Method developmment, trouble shooting pptMethod developmment, trouble shooting ppt
Method developmment, trouble shooting ppt
 
Cornell Computational Chemistry Seminar
Cornell Computational Chemistry SeminarCornell Computational Chemistry Seminar
Cornell Computational Chemistry Seminar
 
Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial TestingBiopharmaceutical Formulation Development CM3 Implementation and Initial Testing
Biopharmaceutical Formulation Development CM3 Implementation and Initial Testing
 
Design Space
Design SpaceDesign Space
Design Space
 
From Screening to QC: Development Considerations for Octet Methods
From Screening to QC: Development Considerations for Octet MethodsFrom Screening to QC: Development Considerations for Octet Methods
From Screening to QC: Development Considerations for Octet Methods
 
Monoclonal antibodies,Production + bioseperartion
Monoclonal antibodies,Production + bioseperartionMonoclonal antibodies,Production + bioseperartion
Monoclonal antibodies,Production + bioseperartion
 
Process Development for Continuous Flow-Through Polishing Purification for mA...
Process Development for Continuous Flow-Through Polishing Purification for mA...Process Development for Continuous Flow-Through Polishing Purification for mA...
Process Development for Continuous Flow-Through Polishing Purification for mA...
 

More from Merck Life Sciences

Launch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeLaunch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide Alternative
Merck Life Sciences
 
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
Merck Life Sciences
 
Use of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationUse of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein Purification
Merck Life Sciences
 
Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...
Merck Life Sciences
 
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
Merck Life Sciences
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Merck Life Sciences
 
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
Merck Life Sciences
 
The Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsThe Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical Audits
Merck Life Sciences
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Merck Life Sciences
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesIdentity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Merck Life Sciences
 
Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...
Merck Life Sciences
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
Merck Life Sciences
 
Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?
Merck Life Sciences
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Merck Life Sciences
 
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Merck Life Sciences
 
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsRisk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Merck Life Sciences
 
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Merck Life Sciences
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
Merck Life Sciences
 
The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...
Merck Life Sciences
 
How to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesHow to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC Therapies
Merck Life Sciences
 

More from Merck Life Sciences (20)

Launch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide AlternativeLaunch of our new Titanium Dioxide Alternative
Launch of our new Titanium Dioxide Alternative
 
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
The Viscosity Reduction Platform: Viscosity-reducing excipients for improveme...
 
Use of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein PurificationUse of Excipients in Downstream Processing to Improve Protein Purification
Use of Excipients in Downstream Processing to Improve Protein Purification
 
Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...Exploring the protein stabilizing capability of surfactants against agitation...
Exploring the protein stabilizing capability of surfactants against agitation...
 
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
The Viscosity Reduction Platform: Viscosity Reducing Excipients for Protein F...
 
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
Characterization of monoclonal antibodies and Antibody drug conjugates by Sur...
 
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
The Role of BioPhorum Extractables Data in the Effective Adoption of Single-U...
 
The Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical AuditsThe Future of Pharma- and Biopharmaceutical Audits
The Future of Pharma- and Biopharmaceutical Audits
 
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
Moving your Gene Therapy from R&D to IND: How to navigate the Regulatory Land...
 
Identity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapiesIdentity testing by NGS as a means of risk mitigation for viral gene therapies
Identity testing by NGS as a means of risk mitigation for viral gene therapies
 
Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...Latest advancements of melt based 3D printing technologies for oral drug deli...
Latest advancements of melt based 3D printing technologies for oral drug deli...
 
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
CAR-T Manufacturing Innovations that Work - Automating Low Volume Processes a...
 
Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?Viral safety of biologics: What's changing with the ICH Q5A revision?
Viral safety of biologics: What's changing with the ICH Q5A revision?
 
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
Improve Operational Efficiency by Over 30% with Product, Process, & Systems A...
 
Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...Insights from a Global Collaboration Accelerating Vaccine Development with an...
Insights from a Global Collaboration Accelerating Vaccine Development with an...
 
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use SystemsRisk-Based Qualification of X-Ray Sterilization for Single-Use Systems
Risk-Based Qualification of X-Ray Sterilization for Single-Use Systems
 
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
Rapid replication competent adenovirus (rRCA) detection: Accelerate your lot ...
 
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
The High Intensity Sweeteners Neotame and Sucralose: 2 Ways to ace the Patien...
 
The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...The Developability Classification System (DCS): Enabling an Optimized Approac...
The Developability Classification System (DCS): Enabling an Optimized Approac...
 
How to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC TherapiesHow to Accelerate and Enhance ADC Therapies
How to Accelerate and Enhance ADC Therapies
 

Recently uploaded

Common Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptxCommon Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptx
patriciaava1998
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
Brian Frerichs
 
DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
Robert Cole
 
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
rightmanforbloodline
 
Professional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine LectureProfessional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine Lecture
DIVYANSHU740006
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
Dr Rachana Gujar
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
Chandrima Spa Ajman
 
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURYDR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
SHAMIN EABENSON
 
Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.
Vishal kr Thakur
 
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSONNEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
SHAMIN EABENSON
 
Bath patient Fundamental of Nursing.pptx
Bath patient Fundamental of Nursing.pptxBath patient Fundamental of Nursing.pptx
Bath patient Fundamental of Nursing.pptx
MianProductions
 
Pediatric Emergency Care for Children | Apollo Hospital
Pediatric Emergency Care for Children | Apollo HospitalPediatric Emergency Care for Children | Apollo Hospital
Pediatric Emergency Care for Children | Apollo Hospital
Apollo 24/7 Adult & Paediatric Emergency Services
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
Dinesh Chauhan
 
GIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure andGIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure and
MuzafarBohio
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DR Jag Mohan Prajapati
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Ear Solutions (ESPL)
 
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
nirahealhty
 
Top Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima SpaTop Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima Spa
Chandrima Spa Ajman
 
Gemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for ArtemiaGemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for Artemia
smuskaan0008
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
VITASAuthor
 

Recently uploaded (20)

Common Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptxCommon Challenges in Dermatology Billing and How to Overcome.pptx
Common Challenges in Dermatology Billing and How to Overcome.pptx
 
Bringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured ApproachBringing AI into a Mid-Sized Company: A structured Approach
Bringing AI into a Mid-Sized Company: A structured Approach
 
DRAFT Ventilator Rapid Reference version 2.4.pdf
DRAFT Ventilator Rapid Reference  version  2.4.pdfDRAFT Ventilator Rapid Reference  version  2.4.pdf
DRAFT Ventilator Rapid Reference version 2.4.pdf
 
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
TEST BANK FOR Health Assessment in Nursing 7th Edition by Weber Chapters 1 - ...
 
Professional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine LectureProfessional Secrecy: Forensic Medicine Lecture
Professional Secrecy: Forensic Medicine Lecture
 
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdfDECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
DECODING THE RISKS - ALCOHOL, TOBACCO & DRUGS.pdf
 
Top massage center in ajman chandrima Spa
Top massage center in ajman chandrima  SpaTop massage center in ajman chandrima  Spa
Top massage center in ajman chandrima Spa
 
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURYDR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
DR SHAMIN EABENSON - JOURNAL CLUB - NEEDLE STICK INJURY
 
Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.Pneumothorax and role of Physiotherapy in it.
Pneumothorax and role of Physiotherapy in it.
 
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSONNEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
NEEDLE STICK INJURY - JOURNAL CLUB PRESENTATION - DR SHAMIN EABENSON
 
Bath patient Fundamental of Nursing.pptx
Bath patient Fundamental of Nursing.pptxBath patient Fundamental of Nursing.pptx
Bath patient Fundamental of Nursing.pptx
 
Pediatric Emergency Care for Children | Apollo Hospital
Pediatric Emergency Care for Children | Apollo HospitalPediatric Emergency Care for Children | Apollo Hospital
Pediatric Emergency Care for Children | Apollo Hospital
 
Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.Tips for Pet Care in winters How to take care of pets.
Tips for Pet Care in winters How to take care of pets.
 
GIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure andGIT BS.pptx about human body their structure and
GIT BS.pptx about human body their structure and
 
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
DELIRIUM BY DR JAGMOHAN PRAJAPATI.......
 
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
Exploring the Benefits of Binaural Hearing: Why Two Hearing Aids Are Better T...
 
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
Can coffee help me lose weight? Yes, 25,422 users in the USA use it for that ...
 
Top Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima SpaTop Rated Massage Center In Ajman Chandrima Spa
Top Rated Massage Center In Ajman Chandrima Spa
 
Gemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for ArtemiaGemma Wean- Nutritional solution for Artemia
Gemma Wean- Nutritional solution for Artemia
 
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to CareLGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
LGBTQ+ Adults: Unique Opportunities and Inclusive Approaches to Care
 

Process Scale Chromatography

  • 1. Merck KGaA Darmstadt, Germany Authors: Marine Maszelin, Emilie Egloff, Nargisse El Hajjami, Josselyn Haas Durr, Nina Weis Process Scale chromatography M Lab™ Collaboration Center Demonstration Day
  • 3. For Upstream, Downstream, and Final Fill, our non- GMP facilities are resource hubs for: • Application & Technology Demonstrations • Education • Complex Process Development, Optimization, and Scale-Up • Troubleshooting and Unit Operation Support • Analytical Modelling • Customer Sizing and Simulation Tools & Methodologies M Lab™ Collaboration Centers Singapore Molsheim, France Sao Paulo, Brazil Burlington, USA Mumbai, India Bangalore, India Shanghai, China Tokyo, Japan Incheon, South Korea
  • 4. 1904 1930 1950s 1970s /80s 1989 1991 1992 1995 2004 2005 2008 2009 2011 2012 2010 2016 2013 2017 Aluminium Oxide Silica Gel ProSep® vA HC Fractogel® EMD SO3 (M), TMAE (M), DMAE (M), DEAE (M) Fractogel® EMD Chelate Fractogel® EMD SE Hicap (M), COO (M) ProSep® vA Ultra Eshmuno® S Eshmuno® Q Eshmuno® HCX Eshmuno® CPX PharmPrep® P Eshmuno® A Eshmuno® P anti-A & P anti-B Natrix® Q Fractogel® EMD TMAE Medcap Fractogel® EMD BioSEC, TMAE Hicap (M), SO3 (S), TMAE (S) Calcium Carbonate LiChroprep® ProSep® Ultra Plus 2020 Eshmuno® CMX A Long History of Bringing Innovative Products to Market 2018 Eshmuno® CP-FT Eshmuno® CPS
  • 6. Used to separate chemical or biological components of a mixture for later use, and a powerful step in the drug purification process. Used for the quantitation and identification of chemical or biological compounds to establish relative proportions of analytes in a mixture. Analytical Chromatography Preparative Chromatography VS
  • 7. The Goal of Preparative Chromatography Isolation of the target compound from a crude feedstock as economical as possible! ... as fast as possible ... as pure as possible ... as much as possible ... as highly concentrated as possible
  • 8. Chromatographic Steps Equilibrate Column is conditioned to suitable pH, ionic strength, polarity, and hydrophobicity for mobile phase A Load Sample containing solutes is applied to the chromatographic bed Wash Bound solutes are washed with mobile phase A to remove unwanted and unbounded molecules Elute Target molecule is eluted from the chromatographic bed by changing conditions to mobile phase B Regenerate Re-equilibration of the chromatographic medium to the initial mobile phase conditions Chromatography Resin Target Protein Unwanted molecules
  • 9. 9 • Enables enhanced mAb purity which are positively charged • Removal of DNA, endotoxins, host cell protein and leached protein A ligands • May be efficient in reducing aggregates • Efficient method for capturing monoclonal antibodies (mAbs) • Removal of trace contaminants such as nucleic acids and host cell proteins to reach the highest level of mAb purity • Contribute to the overall viral clearance strategy for mammalian cell processes How Chromatography is used in a Drug: mAb Purification Process
  • 10. Types of Chromatography and How They Are Used Mode Affinity Ion Exchange Reverse Phase Membrane Hydrophobic Interaction Size Exclusion Capture Purification Polishing Capture: step used to isolate and concentrate the target molecule Moderate to High Purity | High Yield Purification: step used to remove bulk impurities Very High Purity | Balanced Yield Polishing: step used to remove final contaminants Highest Purity | Moderate Yield
  • 11. Which Impurities are Removed by Chromatography Type Host Cell Proteins DNA Virus Leached Protein A Aggregates Protein A Cation Exchange Anion Exchange Somewhat Effective Moderately Effective Extremely Effective Marginally Effective Very Effective
  • 12. Products to Suit a Diversified Landscape of Molecules Type of molecule Chromatography Mode Monoclonal antibody • Affinity • Ion exchange • Mixed-mode Other recombinant proteins • Ion exchange • Mixed-mode • Reversed phase • Affinity • Size exclusion Plasma protein • Ion exchange • Size exclusion • Affinity Vaccine • Ion exchange • Size exclusion Small molecule, peptide • Reversed phase • Ion exchange Removal of impurties For example: • Aggregates • Fragments • Charge variants • HCPs (Host Cell Proteins) • DNA • Virus • Endotoxin • Proteases Impurities depend on expression system, product, and process.
  • 13. Theoretical Plates Theory Assumption: Column consists of a large number of imaginary layers Separation Action: analytes equilibrate between the mobile and stationary phase in each layer Column Efficiency: measured by calculating the height equivalent of a theoretical plate (HETP) Theoretical Plate Column
  • 14. Retention Time DetectorResponse How to read a Chromatogram Injection Retention Time = time between injection and detection of analyte (Capacity factor) Obtaining the optimum resolution (Rs) in the minimum time is the goal when optimizing chromatographic steps Rs= Retention x Selectivity x Efficiency Efficiency Selectivity (Separation Factor) Peak maximum ability of the chromatographic system to ‘chemically’ distinguish between sample components
  • 15. Elution of unbound molecules Elution of unwanted material Elution of target molecule Elution of tightly bound molecules Retention Time DetectorResponse 10-20 Column Volumes 2-4 Column Volumes 2-4 Column Volumes 4 Column VolumesHow to read a Chromatogram
  • 16. Base Bead A A A A A A A AAA A A A A A A A A A A A A A Variable Region Fc Fragment Fab Fragment F(ab)₂ Fragment Heavy Chains Light Chains Specific and selective interaction between target molecule and resin Protein A Affinity Chromatography: Separation Principle
  • 17. Ion Chromatography: Separation Principle Base Bead Negatively Charged Bound Protein Positively Charged Ligand Unbound Protein Bind: proteins attach as they are loaded onto the column at low ionic strength Elute: performed by increasing salt concentration or changing pH to retrieve attached target protein
  • 18. Architecture of Chromatographic Resins O O H3N+- Si O H H O H CH3 CH3 R R R R R R R OH OH Base Material porous, spherical or irregular shaped particles in the µm- range Linker linear or branched chains or tentacles to present the ligands in an optimal way. Ligand Point of Interaction on molecular level: (ionic, hydrophobic, H-bridges, π-π- interaction) Three main parts: Base Material, Linker and Ligand
  • 19. Hydraulic Properties Spherical or Irregular Average size and distribution Functionality Pore diameter and volume 1 Shape 2 Size 3 Porosity 4 Rigidity 5 Chemistry Chromatography Resin – Heart of the Chromatography Unit Operation + More Efficient + Good mass transfer - Higher pressure drop - More expensive - Less Efficient - Poorer Mass Transfer + Lower pressure drop + Less Expensive vs. + Larger surface area → larger capacity + Stronger - Poorer mass transfer - Less surface area → less capacity - weaker + Better mass transfer vs.
  • 20. Different Column Dimensions © Copyright Merck KGaA, Darmstadt Germany Lab-scale, analytical HPLC-instruments Semi-prep 4 mm 10 mm 25 mm 50 mm 100 mm 400 mm Process-scale 800 mm
  • 21. Chromatography Resin Properties and the Factors They Influence Resolution, product purity, removal of impurities, pressure drop, dynamic capacity Throughput, potential scale of manufacturing, maximum operating velocity 1 Binding capacity, selectivity, and recovery 2 Lifespan, ease and efficacy of sanitization, and effectiveness of cleaning in place 5 4 Dynamic binding capacity, flow rate 3 Product recovery, and effectiveness of cleaning in place 6 Mechanical Properties Ligand Density & Distribution Pore Size & Distribution Particle Size & Distribution Chemical Stability Hydrophilicity & Hydrophobicity Source: Handbook of Process Chromatography – Development, Manufacturing, Validation and Economics. 2nd Edition. 2008, Hagel, Gunter, Sofer. <https://www.sciencedirect.com/book/9780123740236/handbook-of-process-chromatography>
  • 22. • Increase Diameter • Constant Bed Height & Linear Flow Rate Scale-Up 22 Preserve the quality of separation achieved at small scale in order to produce comparable results at large scale Economic Scale-Up Challenges 1) Column Size 2) Reuse & Cycles 3) Throughput 4) Costs Technical Scale-Up Challenges 1) Quality of the Separation 2) Comparable Results Impacts 1) Capacity 2) Column Loading 3) Product Titer 4) Lot Size Impacts 1) Process Parameters 2) Packing Efficiency 3) Pressure Drop Constraints 4) Flow Distribution Conventional Scale-Up1 Residence Time Scale-Up2 • Linear increase of Bed Height & Flow Rate • Pressure-Flow Limitations Due to Compressibility Combined Scale-Up2 • Modern resin maintain low pressure drop • Permits scale-up in any dimension at constant residence time • Greater equipment flexibility
  • 24. 2018 2018-2020+ >2025 Biomanufacturing moves to the next generation of biotherapeutic production with the BioContinuum™ Platform Smaller Footprint Less Capital Intense Reduction in Construction Time Reduction in OPEX 90% 90% 70% 90%
  • 25. Intensified Upstream & harvest Intensified Capture In-Line VI In-Line Buffer Flow Through Polishing Continuous UFDF The next generation of chromatography will be important for intensified biomanufacturing and continuous processing ✓ Reduced Footprint ✓ Enhanced Utilization of Protein A Resin ✓ Enables Single-Use and Closed Operations ✓ Increased Productivity ✓ Reduced Footprint & Capital Expenditure ✓ Reduces Consumables Needed Including Buffer Requirements ✓ Enables Single-Use and Closed Operations ✓ Reduced Set-Up and Switching Time
  • 26. 26 Bioreactor Virus Filtration UF/DFProtein A f/t CEX f/t AEXFiltration Eshmuno® CP-FT resin: a novel cation exchange resin used for flow through polishing Tentacular Ligand Chemistry AggregatesMonomer
  • 27. Eshmuno® CP-FT resin: Reduces the volume of columns required to purify 1 kg of mAb Volume for 80 g/L Loading Volume for 1000 g/L Loading Traditional CEX Media Bind/Elute Chromatography Eshmuno® CP-FT resin Flow-Through Chromatography 20cmbedheight 20cmbedheight 12.5 L 1 Lvs.
  • 28. Stay connected! Email: chromconnect@merckgroup.com to sign up for our Quarterly Newsletter Follow Your Curiosity
  • 29. Schedule an in-person or remote visit today. MerckMillipore.com/mlab
  • 30. The vibrant M, M Lab, LiChroprep, Fractogel, Eshmuno, Natrix, ProSep, PharmPrep, and BioContinuum are trademarks of Merck KGaA, Darmstadt, Germany or its affiliates. All other trademarks are the property of their respective owners. Detailed information on trademarks is available via publicly accessible resources. © 2020 Merck KGaA, Darmstadt, Germany and/or its affiliates. All Rights Reserved.